Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Complex synthesis yields breast-cancer therapy

Nature volume 468, pages 608–609 (2010)Cite this article

Subjects

Drug approval marks culmination of a marathon trek from sea sponges to clinic.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Heidi Ledford
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Drug development from marine natural products

Related external links

US Food and Drug Administration: Eribulin mesylate

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ledford, H. Complex synthesis yields breast-cancer therapy. Nature 468, 608–609 (2010). https://doi.org/10.1038/468608a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/468608a

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing